Posts in tag

Type 2 diabetes


Enabling pharmacists to manage chronic conditions will help ensure patients do not fall through the cracks, a Guild leader says  Pharmacists are playing a key role in the delivery of …

The management of diabetes in older people presents unique challenges due to multiple factors including comorbidities, polypharmacy, frailty, and age-related physiological changes. By Dr Jenny Gowan AM, PhD, Grad Dip …

Australian guidelines for the management of type 2 diabetes state that overtreatment of diabetes is common in older adults and should be avoided.1 Deintensification or simplification of complex regimens is …

Prevalence of add-on therapy in people with type 2 diabetes is “low” and should be increased to save lives, PBS records analysis finds More Australians with type 2 diabetes need …

Eli Lilly’s Mounjaro will be on the private scrip market by the end of September Revolutionary new type 2 diabetes drug Mounjaro – which is almost better known for producing …

Eli Lilly’s Mounjaro would need “substantial price reduction”, says PBAC Mounjaro, the type-2 diabetes medication that the New York Times recently predicted “’could overshadow Ozempic” has been refused funding via …

Pharmacists can make a big difference to the lives of people with diabetes, says credentialled diabetes educator (CDE) Jayne Lehmann. “They can pick up a lot about a person from …

Healthcare professionals can foster timely insulin initiation by supporting patients with realistic, accurate perceptions of diabetes and its treatment from day one. A recent study1 provides insights into some of …

Guidelines are flawed and must be revised as type 2 diabetes is reversible, says the 2020 Australian of the Year. Dietary1 and clinical guidelines2 must change along with our love …

Diabetic retinopathy (DR) is the leading cause of preventable blindness of working-age adults in the world.1 In Australia it is one of the top five causes of irreversible blindness among …

Melbourne lockdowns see gestational diabetes cases rise, while experts warn women are missing out on funded-education and support. COVID lockdowns could be behind an increase seen in the rate of …

‘Cholesterol complacency’ call to action For the first time in nearly a decade, new data highlights the potential extent of the cholesterol problem among high-risk patents costing the economy $1.5 …